News

Danaher has entered a partnership with AstraZeneca to scale precision medicine, including developing the next generation of AI-powered diagnostics This partnership aims to create a framework for rapid diagnostics research, development and commercialization Danaher, through its Centers for Enabling…

VISTA, California, April 25, 2025 – Leica Biosystems is pleased to announce the debut of its latest digital pathology innovation, the Aperio FL digital system, at the American Association of Cancer Researchers (AACR) Annual Meeting in Chicago, Illinois, from April 25-30, 2025. The Aperio FL digital…

Melbourne, Australia – April 2, 2025 – Leica Biosystems, a global leader in anatomic pathology solutions, and Advanced Cell Diagnostics (ACD), a Bio-Techne brand and a global leader in spatial biology, today announced an expansion of their longstanding partnership to offer innovative spatial…

Suzhou, China - March 26, 2025 - Leica Biosystems, a global leader in anatomic pathology, today announced a strategic partnership with CellCarta, a globally recognized Contract Research Organization laboratory serving the biopharmaceutical industry. This partnership combines Leica Biosystems'…

Leica Biosystems is pleased to announce the launch of two new primary antibodies, PD-L1 and HER2, developed to support cancer research and therapy development. These antibodies, widely used in studying breast, lung, and other cancers, underscore our commitment to empowering pharmaceutical partners…

January 28, 2025 – Nussloch, Germany. Leica Biosystems, a global leader in anatomic pathology, is known for its high-quality histology solutions. Today, the company announced the next iteration in its staining and coverslipping portfolio, the HistoCore CHROMAX Workstation (WS). Today, many…

Leica Biosystems, a cancer diagnostics company and a global leader in workflow solutions, and Molecular Instruments® (MI), the inventor of the HCR™ Imaging technology, today announced a partnership to enable fully integrated RNA-ISH using the BOND RX and BOND RXm research staining systems. …

January 17, 2025 - VISTA, CA – Building on 25 years of leading innovation, we are excited to unveil the latest groundbreaking advancements for our Aperio GT 450 Digital Pathology Scanner The Aperio GT 450 scanner’s proven technology, renowned for performance and reliability, is taken to the next…

NEWCASTLE UPON TYNE, January 16, 2025 – Leica Biosystems, a global leader in anatomic pathology, has received a Clinical Laboratory Improvement Amendments (CLIA) certification for its state-of-the-art research and development facility in Newcastle, United Kingdom. A CLIA certification means a…

Combining leading hardware and software is expected to provide a compelling solution for digital pathology users across the full translational medicine paradigm, from early biomarker discovery to clinical trials, and through to routine diagnostics. Vista, CA, and Albuquerque, NM, January 8, 2025 –…